THIAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Thiamine patents expire, and what generic alternatives are available?
Thiamine is a drug marketed by Abraxis Pharm, Aspiro, Bel Mar, Caplin, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Gland, Hospira, Luitpold, Mylan Institutional, Onesource Specialty, Parke Davis, Sagent Pharms Inc, Watson Labs, West-ward Pharms Int, and Wyeth Ayerst. and is included in twenty NDAs.
The generic ingredient in THIAMINE is thiamine hydrochloride. There are seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the thiamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thiamine
A generic version of THIAMINE was approved as thiamine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for THIAMINE?
- What are the global sales for THIAMINE?
- What is Average Wholesale Price for THIAMINE?
Summary for THIAMINE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 20 |
| Drug Prices: | Drug price information for THIAMINE |
| Drug Sales Revenues: | Drug sales revenues for THIAMINE |
| DailyMed Link: | THIAMINE at DailyMed |
US Patents and Regulatory Information for THIAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | THIAMINE HYDROCHLORIDE | thiamine hydrochloride | INJECTABLE;INJECTION | 080509-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sagent Pharms Inc | THIAMINE HYDROCHLORIDE | thiamine hydrochloride | INJECTABLE;INJECTION | 206106-001 | Dec 1, 2017 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Dr Reddys | THIAMINE HYDROCHLORIDE | thiamine hydrochloride | INJECTABLE;INJECTION | 080571-001 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Bel Mar | THIAMINE HYDROCHLORIDE | thiamine hydrochloride | INJECTABLE;INJECTION | 080712-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
